Literature DB >> 30836204

Dust mite-derived Der f 3 activates a pro-inflammatory program in airway epithelial cells via PAR-1 and PAR-2.

Bizhou Li1, Zehong Zou2, Fanmei Meng1, Eyal Raz3, Yuye Huang1, Ailin Tao4, Yuncan Ai5.   

Abstract

Protease activity of allergens has been suggested to be involved in the pathogenesis of allergic diseases. The major allergen Der f 3 from Dermatophagoides farinae harbors serine protease activity, but its immunopathogenesis remains unclear. This study aims to explore the effect of Der f 3 on the airway epithelial barrier and on the molecular pathways by which Der f 3 induces inflammation. RNA-seq was performed to identify differentially expressed genes in bronchial airway epithelial cells (AEC) between native Der f 3 and heat-inactivated (H) Der f 3, coupled with real-time PCR (RT-PCR) and ELISA for validation. Unlike other protease allergens such as that induce Th2-promoting alarmins (IL-25, IL-33, TSLP) in AECs, Der f 3 induced pro-inflammatory cytokines and chemokines including IL-6, IL-8 and GM-CSF, which are known to promote Th17 response. These pro-inflammatory mediators were induced by Der f 3 via the MAPK and NF-κB pathways as well as the store-operated calcium signaling. Gene silencing with small interfering RNA in A549 and BEAS-2B cells indicated that activation of AECs by Der f 3 was mainly dependent on protease-activated receptor 2 (PAR-2), while PAR-1 was also required for the full activation of AECs. Double knock-down of PAR-1 and PAR-2 largely impaired Der f 3-inducecd IL-8 production and subsequent signaling pathways. Our data suggest that Der f 3 induces pro-inflammatory mediators in human epithelial cell lines via the PARs-MAPK-NF-κB axis. Our results provide a molecular mechanism by which Der f 3 may trigger the Th17-skewed allergic response toward house dust mites.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Airway epithelial cell; Der f 3; House dust mite (HDM); Inflammation; Protease; Protease-activated receptor (PAR)

Mesh:

Substances:

Year:  2019        PMID: 30836204     DOI: 10.1016/j.molimm.2019.02.018

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  Candida albicans Sap6 Initiates Oral Mucosal Inflammation via the Protease Activated Receptor PAR2.

Authors:  Rohitashw Kumar; Isolde Gina Rojas; Mira Edgerton
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

2.  Endocrine Disruptor Bisphenol A (BPA) Triggers Systemic Para-Inflammation and is Sufficient to Induce Airway Allergic Sensitization in Mice.

Authors:  Lucas Fedele Loffredo; Mackenzie Elyse Coden; Sergejs Berdnikovs
Journal:  Nutrients       Date:  2020-01-28       Impact factor: 5.717

3.  Pollen Proteases Play Multiple Roles in Allergic Disorders.

Authors:  Ricardo Gaspar; Mafalda Ramos de Matos; Luísa Cortes; Isabel Nunes-Correia; Ana Todo-Bom; Euclides Pires; Paula Veríssimo
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

Review 4.  Epithelial barrier dysfunction in ocular allergy.

Authors:  Neera Singh; Yolanda Diebold; Srikant K Sahu; Andrea Leonardi
Journal:  Allergy       Date:  2021-11-28       Impact factor: 14.710

5.  Novel inhibitors and activity-based probes targeting serine proteases.

Authors:  Timothy E G Ferguson; James A Reihill; S Lorraine Martin; Brian Walker
Journal:  Front Chem       Date:  2022-09-28       Impact factor: 5.545

Review 6.  More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis.

Authors:  Andreas Frey; Lars P Lunding; Johanna C Ehlers; Markus Weckmann; Ulrich M Zissler; Michael Wegmann
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

Review 7.  Dysregulation of the epithelial barrier by environmental and other exogenous factors.

Authors:  Yasutaka Mitamura; Ismail Ogulur; Yagiz Pat; Arturo O Rinaldi; Ozge Ardicli; Lacin Cevhertas; Marie-Charlotte Brüggen; Claudia Traidl-Hoffmann; Mubeccel Akdis; Cezmi A Akdis
Journal:  Contact Dermatitis       Date:  2021-09-17       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.